Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2023-10-04 00:00:00 ET · period of report 2023-10-03 · accession 0001209191-23-051885 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-04 | 2023-10-03 | TVTX | Heerma Peter | Chief Commercial Off | S - Sale | $8.25 | -3,091 | 80.3K | -4% | -$25.5K |
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-03 | S | D | 3,091 | $8.25 | 80,257 | D | — | — | (F2) Includes 1,279 shares of the Issuer's common stock acquired by the reporting person on May 31, 2023 pursuant to an employee stock purchase program. |